Metabolic Disease Drugs

Stay updated on Metabolic Disease Drugs trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Metabolic Disease Drugs's role in Therapeutic Areas & Drug Cases and Pharma.

A general view of AbbVie, a biopharmaceutical company.
Pharma

AbbVie joins the weight loss race

In a $350m deal, AbbVie bought a Danish weight loss drug in Phase 1 clinical trials.

Cassie McGrath

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Healthcare Brew